In September, Analytik Jena set up a joint application center, in cooperation with lab furniture supplier Wesemann, for teaching and research at the Fresenius University of Applied Sciences in Hessen, Germany. Analytik Jena provided six instruments.
Halma named Jennifer Ward, its Group Talent Director, as a director in September.
In October, Sartorius announced that CFO Jörg Pfirrmann will leave the company in July 2017.
Hitachi High-Technologies Europe announced in October that it will acquire Swedish-based Spectral Solutions, its Nordic region distributor for electron microscopes. Spectral Solutions will become Hitachi High-Technologies Europe’s Swedish office. Spectral Solutions has seven employees. Hitachi High-Technologies Europe has 117 employees.
In October, PerkinElmer named Samuel R. Chapin to the Board. He most recently served as executive vice chairman of Global Corporate & Investment Banking for Bank of America Merrill Lynch.
Agilent Technologies named Roeland G.W. Verhaak, PhD, as the winner of its Early Career Professor Award in October. He was selected for his contributions to the implementation of transcriptomics, genomics and big-data analysis to the classification and diagnosis of various cancer types. He recently joined the Jackson Laboratory as professor and associate director of computational biology.
In October, Agilent Technologies presented an Agilent Thought Leader Award to Dr. Scott Lowe in recognition of his contributions to the identification of key genes and their characterization as therapeutic targets using novel genetic screens and animal models. He is chair of the Cancer Biology & Genetics Program at the Sloan Kettering Institute as well as chair of the Geoffrey Beene Cancer Research Center at the Memorial Sloan Kettering Cancer Center. The Award will support his work on the development and implementation of next generation CRISPR-based genetic screens to systematically identify and characterize novel targets for cancer therapeutics.
bioMérieux’s third quarter revenue for Industrial Applications grew 7.0%, 8.7% at constant exchange rates, to €93.6 million ($102.9 million = €0.91 = $1). Sales of the VIDAS, VITEK and culture media lines resulted in increased sales to the food industry.
Merck KGaA named Isabel De Paoli as chief strategy officer, effective October 1. She heads the newly created Group Strategy and Transformation function. She assumes the new role in addition to her current role as head of Group Communications.
GE announced on its third quarter conference call that GE Healthcare Life Science revenue grew 11% organically and orders rose 4% organically. Bioprocess orders increased 5%. Excluding a major prior year order, Bioprocess orders were up 22%.
In October, Eppendorf announced the creation of a new Board position that includes Sales, Marketing and Service in order to focus on developing the company’s market presence. As a result, Dr. Ralf Hermann, chief Marketing & Portfolio officer, will lead the Board this month.
Xylem third quarter revenue for the Test business of its Water Infrastructure segment declined 8% due to a large project in Latin America in the prior year and lower government, and oil and gas sales in the US.
In November, Illumina announced that Christian O. Henry, executive vice president and CCO, will leave the company in January 2017. Mark Van Oene, vice president and general manager of the Americas Commercial Operation, will serve as interim CCO.